QuickView for Mu opioid receptor (biogroup)

1. Drug target sets for approved compounds
2. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
3. L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
4. OMIM - Adverse drug effect
5. L1000 CMAP - Adipose MSC ASC52telo cells with shRNA-mediated gene knockdown

There were no matches for Mu opioid receptor

1. Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opi…
2. Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia Afte…
3. Mu Opioid Receptor 1 Expression and Activation Patterns in Colorectal Cancer
4. To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effect…
5. MOR-1 Expression in Colorectal Cancer and Disease-free Survival Relationship. Five-year Follow-up.